These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3179481)

  • 1. Novel compositions of emulsified perfluorochemicals for biological uses.
    Sharma SK; Lowe KC; Davis SS
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):447-50. PubMed ID: 3179481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interfacial properties as stability predictors of lecithin-stabilized perfluorocarbon emulsions.
    Yoon JK; Burgess DJ
    Pharm Dev Technol; 1996 Dec; 1(4):333-41. PubMed ID: 9552317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The elimination peculiarities of perfluorocarbon emulsions stabilized with egg yolk phospholipid.
    Putyatina TK; Aprosin UD; Afonin NI
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1281-5. PubMed ID: 7849934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Various physico-chemical and biological properties of perfluorodecalin emulsions].
    Chaplygina ZA; Kuznetsova IN; Gokhman NSh; Domracheva VS; Maksimov BN
    Probl Gematol Pereliv Krovi; 1982 Oct; 27(10):8-12. PubMed ID: 7178053
    [No Abstract]   [Full Text] [Related]  

  • 5. [Perfluorochemicals as artificial blood. problems and actual development (author's transl)].
    Schnoy N; Pfannkuch F; Beisbarth H
    Anaesthesist; 1979 Nov; 28(11):503-10. PubMed ID: 118676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluorochemical emulsions with fluorinated surfactants and anticancer drugs.
    Fung BM; O'Rear EA; Afzal J; Frech CB; Mamrosh DL; Gangoda M
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):439-40. PubMed ID: 3179478
    [No Abstract]   [Full Text] [Related]  

  • 7. Phospholipid vesiculated fluorocarbons--promising trend in blood substitutes.
    Gross U; Rüdiger S; Reichelt H; Draffehn J
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):831-3. PubMed ID: 1391517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitation of complement activation by perfluorocarbon emulsions: superiority of lecithin-emulsified preparations.
    Hammerschmidt DE; Vercellotti GM
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):431-8. PubMed ID: 3263156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular behavior of a perfluorochemical emulsion.
    Tsuda Y; Yamanouchi K; Okamoto H; Yokoyama K; Heldebrant C
    J Pharmacobiodyn; 1990 Mar; 13(3):165-71. PubMed ID: 2374085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inorganic additives on solutions of nonionic surfactants V: Emulsion stability.
    Schott H; Royce AE
    J Pharm Sci; 1983 Dec; 72(12):1427-36. PubMed ID: 6663480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous emulsified perfluorochemicals on hepatic cytochrome P-450.
    Huang R; Cooper DY; Sloviter HA
    Biochem Pharmacol; 1987 Dec; 36(24):4331-4. PubMed ID: 3689455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of fluorocarbons and surfactants for in vivo applications. New perfluoroalkylated polyhydroxylated surfactants.
    Riess JG; Arlen C; Greiner J; Le Blanc M; Manfredi A; Pace S; Varescon C; Zarif L
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):421-30. PubMed ID: 3052646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of emulsion interfacial membrane characteristics on Ostwald ripening in a model emulsion.
    Han SW; Song HY; Moon TW; Choi SJ
    Food Chem; 2018 Mar; 242():91-97. PubMed ID: 29037741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emulsions of perfluorinated solvents for intravascular gas transport.
    Clark LC; Wesseler EP; Kaplan S; Miller ML; Becker C; Emory C; Stanley L; Becattini F; Obrock V
    Fed Proc; 1975 May; 34(6):1468-77. PubMed ID: 1126444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorocarbon emulsions--the stability issue.
    Postel M; Riess JG; Weers JG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):991-1005. PubMed ID: 7849970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of the enhanced stability of emulsions of perfluoro-organic compounds in the circulatory bed].
    Pavlova-Verevkina OB; Aprosin IuD; Afonin NI
    Gematol Transfuziol; 1987 May; 32(5):50-2. PubMed ID: 3609686
    [No Abstract]   [Full Text] [Related]  

  • 17. Degradation of kinetically-stable o/w emulsions.
    Capek I
    Adv Colloid Interface Sci; 2004 Mar; 107(2-3):125-55. PubMed ID: 15026289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of selected properties on the stability of pharmaceutical emulsions.
    Wojdak H; Drobnicka B; Zientarska G; Gadomska-Nowak M
    Pharmazie; 1991 Feb; 46(2):120-5. PubMed ID: 1852760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of semifluorinated alkanes in blood-substitutes.
    Meinert H; Knoblich A
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):583-95. PubMed ID: 8117848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial blood emulsifiers.
    Schmolka IR
    Fed Proc; 1975 May; 34(6):1449-53. PubMed ID: 1126441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.